The effect of omega-3 on the side effects of tamoxifen in women with breast cancer
- Conditions
- Quqlity of life, side effect of menopauses,sexual dysfunction.-
- Registration Number
- IRCT201104052515N3
- Lead Sponsor
- Vice chancellor for research, shiraz university of medical science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 140
Medical record review identified female patients who were initially diagnosed as stage 1 and 2 with breast cancer prior to menopause age or menopause are not related to medication or surgery, married, be literate, signed and confirmed consent form, completed adjuvant treatment such as chemotherapy, hormonal therapy with tamoxifen or suffered by tamoxifen treatment side effects such as; hot flashes, sexual dysfunction, night sweats, negative impact on life quality, that met the inclusion criteria.
After deletion of patients who met specific exclusion criteria such as; high blood pressure, blood lipids, renal and thyroid dysfunction, history of allergy to O-3, using medication or food complementary for the purpose of preventing or reducing complications and/or side effects of tamoxifen treatment, using medication to treat mental disorder, having sever and progressive disease(s), disease relapsation, those patients who were initially or latelly diagnosed with advanced stages (>2) of breast cancer and finally those one unwillingness to continue participation in research.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Hot flashes. Timepoint: befor intervention and three months after intervention. Method of measurement: part of the grin questionnaire.;Night sweats. Timepoint: before intervention and Three months after intervention. Method of measurement: part of the grin questionnaire.;Quality of life. Timepoint: befor intervention and three months after intervention. Method of measurement: QLQ-C30 questionnaire.;Sexual dysfunction. Timepoint: before intervention and three months after intervention. Method of measurement: FSFI questionnaire.
- Secondary Outcome Measures
Name Time Method